Timothy M. Schmidt
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 23
- Chronic Myeloid Leukemia Treatments 2
-
- Protein Degradation and Inhibitors 16
- Co-authors
- Rafaël Fonseca (3 shared papers)Saad Z. Usmani (1 shared paper)Natalie S. Callander (17 shared papers)Luciano J. Costa (13 shared papers)Smith Giri (10 shared papers)Bhagirathbhai Dholaria (11 shared papers)Susan Bal (11 shared papers)Eva Medvedova (11 shared papers)
- Journals
- Blood (6 papers)Blood Cancer Journal (3 papers)Journal of Clinical Oncology (2 papers)Transplantation and Cellular Therapy (2 papers)The Journal of Infectious Diseases (1 paper)
- Partner nations
- United StatesGreeceBelgium
In The Last Decade
Timothy M. Schmidt
27 papers receiving 603 citations
Timothy M. Schmidt's Hit Papers
Peers
Comparison fields: 5 of 42
- Hematology 499
- Oncology 238
- Molecular Biology 347
- Genetics 49
- Virology 18
Countries citing papers authored by Timothy M. Schmidt
This map shows the geographic impact of Timothy M. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Schmidt more than expected).
Fields of papers citing papers by Timothy M. Schmidt
This network shows the impact of papers produced by Timothy M. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Schmidt. The network helps show where Timothy M. Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy M. Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 151 | |
| 2 | 2019 | 113 | |
| 3 | 2021 | 91 | |
| 4 | Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2023 | 82 |
| 5 | 2014 | 62 | |
| 6 | 2019 | 20 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2021 | 11 | |
| 10 | 2018 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 2 |
About Timothy M. Schmidt
Timothy M. Schmidt is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Infectious Diseases, having authored 29 papers that have together received 615 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), Protein Degradation and Inhibitors (16 papers), Peptidase Inhibition and Analysis (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Hematology (499 citations), Oncology (238 citations), Molecular Biology (347 citations), Genetics (49 citations) and Virology (18 citations). Timothy M. Schmidt has collaborated with scholars based in United States, Greece and Belgium. Frequent co-authors include Rafaël Fonseca, Saad Z. Usmani, Natalie S. Callander, Luciano J. Costa, Smith Giri, Bhagirathbhai Dholaria, Susan Bal, Eva Medvedova, Kelly Godby and Aric C. Hall. Their work appears in journals such as Blood, Blood Cancer Journal, Journal of Clinical Oncology, Transplantation and Cellular Therapy and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.